Search by Drug Name or NDC

    NDC 68071-1311-03 BUPROPION HYDROCHLORIDE 300 mg/1 Details

    BUPROPION HYDROCHLORIDE 300 mg/1

    BUPROPION HYDROCHLORIDE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NuCare Pharmaceuticals,Inc.. The primary component is BUPROPION HYDROCHLORIDE.

    Product Information

    NDC 68071-1311
    Product ID 68071-1311_f0fb49be-2d1f-319e-e053-2995a90aae39
    Associated GPIs 58300040107530
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name BUPROPION HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name BUPROPION HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name BUPROPION HYDROCHLORIDE
    Labeler Name NuCare Pharmaceuticals,Inc.
    Pharmaceutical Class Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210497
    Listing Certified Through 2024-12-31

    Package

    NDC 68071-1311-03 (68071131103)

    NDC Package Code 68071-1311-3
    Billing NDC 68071131103
    Package 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-1311-3)
    Marketing Start Date 2022-11-23
    NDC Exclude Flag N
    Pricing Information N/A
    << 68071-1288-09 68071-1317-00 >>

    Contents